Zacks Investment Management’s iShares MSCI Finland ETF EFNL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.38M Buy
48,584
+42,833
+745% +$2.12M 0.02% 326
2025
Q4
$275K Buy
5,751
+448
+8% +$20.3K ﹤0.01% 599
2025
Q3
$227K Buy
+5,303
New +$221K ﹤0.01% 648
2023
Q3
Sell
-6,556
Closed -$230K 637
2023
Q2
$230K Sell
6,556
-27,615
-81% -$1.03M ﹤0.01% 576
2023
Q1
$1.31M Buy
34,171
+27,043
+379% +$1.03M 0.02% 328
2022
Q4
$267K Buy
+7,128
New +$252K ﹤0.01% 516
2021
Q3
Sell
-23,516
Closed -$1.16M 617
2021
Q2
$1.16M Buy
23,516
+1,289
+6% +$63.5K 0.02% 348
2021
Q1
$1M Sell
22,227
-1,183
-5% -$54.1K 0.02% 363
2020
Q4
$1.04M Buy
+23,410
New +$992K 0.02% 345
2020
Q1
Sell
-10,222
Closed -$389K 524
2019
Q4
$389K Sell
10,222
-3,782
-27% -$140K 0.01% 468
2019
Q3
$509K Sell
14,004
-797
-5% -$29.1K 0.01% 436
2019
Q2
$557K Buy
+14,801
New +$568K 0.01% 446

Other funds holding EFNL

Zacks Investment Management's EFNL Position: Q1 2026 in Review

Zacks Investment Management increased its iShares MSCI Finland ETF (EFNL) stake by 745% in Q1 2026, buying an estimated $2.12M and bringing the position to 48,584 shares worth $2.38M. The position accounts for 0.02% of the portfolio, ranked #326.

Zacks Investment Management first reported a position in EFNL in Q2 2019 and has held it in 12 quarters since. 21 funds tracked by Wall St. Rank hold EFNL as of Q1 2026.

  • Zacks Investment Management held 48,584 shares of iShares MSCI Finland ETF worth $2.38M as of Q1 2026.
  • Zacks Investment Management bought 42,833 iShares MSCI Finland ETF shares in Q1 2026, an estimated $2.12M.
  • iShares MSCI Finland ETF made up 0.02% of Zacks Investment Management's portfolio in Q1 2026, its #326 holding.
  • Zacks Investment Management first reported a position in iShares MSCI Finland ETF in Q2 2019 and has held it in 12 quarters since.
  • 21 funds tracked by Wall St. Rank held iShares MSCI Finland ETF as of Q1 2026.

Based on Zacks Investment Management's 13F filing for Q1 2026, filed 14 May 2026.